Nanjing Yoko Pharmaceutical

Nanjing Yoko Pharmaceutical is a comprehensive pharmaceutical company headquartered in Nanjing, China, specializing in the R&D, production, and commercialization of high-end generic and innovative medicines. Since its inception in 2003, the company has focused on critical therapeutic areas including anti-infectives, cardiovascular diseases, and gastrointestinal disorders. Nanjing Yoko operates advanced GMP-certified manufacturing facilities and a dedicated research institute to support its robust product pipeline. The company is particularly known for its expertise in injectable formulations and its strategic focus on first-to-market generics in the Chinese domestic market. Their portfolio includes a wide range of antibiotics and proton pump inhibitors that serve a significant patient population in China.